Sumitomo Pharma shares plunge nearly 16% despite greenlight for Parkinson's treatment

Thread starter International: Top News And Analysis
Start date Feb 20, 2026

International: Top News And Analysis

Guest

Feb 20, 2026

Shares of Japan's Sumitomo Pharma fell over 15% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Sumitomo Pharma shares plunge nearly 16% despite greenlight for Parkinson's treatment

Prefix: N/A

Forum: World News

Start date: Feb 20, 2026

Last reply date: Feb 20, 2026

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Feb 20, 2026

Replies: 0

Views: 3

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search